Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check16 days agoChange DetectedA new Revision: v3.4.3 entry was added to the history, and the previous Revision: v3.4.2 entry was removed.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedA new Revision: v3.4.2 has been added, and earlier entries including a government-funding notice and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check51 days agoChange DetectedAdded an administrative notice about potential processing delays due to a lapse in government funding. Version updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check58 days agoChange DetectedGlossary visibility has been added, and the history view now uses green and red highlights to show additions and deletions, with an updated revision label (Revision: v3.4.0).SummaryDifference0.8%

- Check66 days agoChange DetectedA new revision entry v3.3.4 has been added to the history, and v3.3.3 has been removed. This keeps the historical record of the study's documentation up to date.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.